Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Mabs|April 26, 2012
Galactosylation variations in marketed therapeutic antibodiesT Shantha Raju, Robert E JordanMabs|April 20, 2010
Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?Randall J Brezski, Robert E JordanOncoimmunology|July 29, 2016
Tumor evasion of humoral immunity mediated by proteolytic impairment of antibody triggered immune effector functionNingyan Zhang, Robert E Jordan, Zhiqiang AnThescientificworldjournal|May 31, 2011
The origins, specificity, and potential biological relevance of human anti-IgG hinge autoantibodiesRandall J Brezski, David M Knight, Robert E JordanMabs|November 30, 2011
The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hingeRandall J Brezski, Allison Oberholtzer, Brandy Strake, et al.Oncoimmunology|September 20, 2018
Proteinase-nicked IgGs: an unanticipated target for tumor immunotherapyRobert E Jordan, Xuejun Fan, Georgina Salazar, et al.Breast Cancer Research : BCR|June 3, 2018
Proteolytic single hinge cleavage of pertuzumab impairs its Fc effector function and antitumor activity in vitro and in vivoHao-Ching Hsiao, Xuejun Fan, Robert E Jordan, et al.Science (New York, N.Y.)|November 25, 2003
An atomic-level view of melting using femtosecond electron diffractionBradley J Siwick, Jason R Dwyer, Robert E Jordan, et al.Mabs|May 2, 2015
An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functionsMichelle Kinder, Allison R Greenplate, William R Strohl, et al.Molecular Immunology|December 26, 2007
Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluidMary H Ryan, Diane Petrone, Jennifer F Nemeth, et al.Pageof 4